Aperio Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Aperio Group’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-41,461	Closed	-$1.79M	–	2064
2015 Q3	$1.79M	Buy	41,461 +1,531	+4%	+$64.6K	0.02%	765
2015 Q2	$1.69M	Buy	39,930 +10,633	+36%	+$448K	0.02%	780
2015 Q1	$1.14M	Buy	29,297 +3,848	+15%	+$148K	0.01%	897
2014 Q4	$857K	Buy	25,449 +11,277	+80%	+$398K	0.01%	966
2014 Q3	$496K	Buy	14,172 +1,335	+10%	+$45.8K	0.01%	1134
2014 Q2	$422K	Sell	12,837 -2,160	-14%	-$73.9K	0.01%	1218
2014 Q1	$553K	Buy	+14,997	New	+$550K	0.01%	1281
2013 Q4	–	Hold	0	–	–	–	1640

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Aperio Group's WX Position: Q4 2015 in Review

Aperio Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 41,461 shares — an estimated $1.79M sold.

Aperio Group first reported a position in WX in Q1 2014 and held it in 7 quarters. The position peaked at $1.79M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Aperio Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Aperio Group sold 41,461 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $1.79M.
Aperio Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 7 quarters.
Aperio Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $1.79M in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Aperio Group's 13F filing for Q4 2015, filed 21 Jan 2016.